Risk factors of impaired fasting glucose and type 2 diabetes in Yaoundé, Cameroon: a cross sectional study by unknown
RESEARCH ARTICLE Open Access
Risk factors of impaired fasting glucose and type
2 diabetes in Yaoundé, Cameroon: a cross
sectional study
Clement Nyuyki Kufe1,2*, Kerstin Klipstein-Grobusch1,3, Fezeu Leopold4, Felix Assah2, George Ngufor2,
George Mbeh2, Vivian Nchanchou Mbanya2,5 and Jean Claude Mbanya2
Abstract
Background: The prevalence of diabetes is increasing worldwide, particularly in low and middle income countries,
where treatment and control are often unavailable and inaccessible. Information on risk factors at local and regional
levels is of utmost importance for tailored prevention programmes to curb the rise in diabetes.
The current study was undertaken to investigate the prevalence of Impaired Fasting Glucose (IFG)/Type 2 Diabetes
(T2D) and its risk factors in the adult population in Biyem-Assi-Yaoundé, Cameroon.
Methods: Information on cardiovascular risk factors using the WHO STEPwise approach was obtained for 1623 men
and women aged 25 years and older of the CAMBoD Project in Biyem-Assi, Yaoundé, Cameroon. T2D was defined
as fasting capillary glucose (FCG) ≥ 7.0 mmol/l and/or being on diabetes medication, IFG/T2D as FCG ≥ 6.1 mmol/l
and/or being on diabetes medication. Descriptive statistics and multivariate logistic regression analyses were used
to describe prevalence of IFG/T2D, prevalence of risk factors for IFG/T2D and to investigate the association of risk
factors with prevalence of IFG/T2D.
Results: Prevalence of T2D and of IFG/T2D was 3.3% and 5.7%. Prevalence of hypertension, obesity and abdominal
obesity (elevated waist circumference) was 26.6%, 28.4% and 34.9%, respectively. Age and abdominal obesity were
significantly associated with IFG/T2D in multivariate logistic regression.
Conclusion: For successful primary prevention of T2D in the general population in Cameroon tailored efforts to
address obesity, particularly abdominal obesity, and associated life-style factors are warranted.
Keywords: Diabetes, Impaired fasting glucose, Prevention, Non-communicable diseases, Low and middle income
countries
Background
Prevalence of type 2 diabetes (T2D) in both developed
and developing countries is expected to increase dramat-
ically from 246 million people (6.0%) aged 20 to 79 in
2007 [1] to 382 million in 2013 and to a projected 592
million people by 2035 [2]. About 175 million people
with diabetes are undiagnosed. Diabetes caused 5.1 mil-
lion deaths in 2013 and impact considerably on people
under the age of 60 years. In Africa, 76.0% of deaths due
to diabetes affected this age group [2]. The burden of
T2D is particularly high in low and middle income
countries [1-4]; for Africa prevalence of T2D was 4.5%
in 2011, 5.7% in 2013 and is projected to increase to
6.0% by 2035 with the highest projected increase
(109.6%) in the number of adults aged 20-79 years [2].
For Cameroon prevalence of T2D was 0.8% in 2003, pro-
jections for 2030 estimate diabetes prevalence to be 4.8%
[5,6]. The rapid urbanisation in sub-Saharan Africa
coupled with sedentary lifestyle and increased adiposity
in urban areas is a major determinant in the increasing
prevalence of diabetes and cardiovascular diseases.
Urban residence is associated with a more than twice
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increased risk of diabetes or IFG [4]. IFG identifies risk
state for future diabetes, cardiovascular disease and
premature mortality. Determining IFG in asymptomatic
individuals allows for prevention strategies to be imple-
mented that can delay or prevent onset of T2D. Overall
a prevalence of 5.0% and more for IFG has been ob-
served, varying across different age groups and between
populations [5]. Age-adjusted prevalence of IFG in World
Health Organisation’s African region was 9.7% in 2011 as
compared to global estimates of 6.5%. [5].
T2D is responsible for major contemporary causes of
morbidity and mortality including cardiovascular dis-
eases (CVD), retinopathies, nephropathies and neuropa-
thies. Fifty percent of people living with T2D die of
cardiovascular disease [2]. Most of T2D cases could be
controlled and prevented via lifestyle modification. Fac-
tors that affect the onset of T2D are well known, such as
age, ethnicity and modifiable risk factors like obesity,
physical inactivity, dietary intake, tobacco and excessive
alcohol consumption [6,7], though their prevalence and
thus prevention potential may differ according to geo-
graphical and cultural context. IFG indicates above
normal fasting blood glucose levels but lower than
threshold for diagnosis of diabetes. IFG is a strong risk
marker for the development of diabetes and associated
with increased CVD risk [8]. Previous studies showed
that during the five years preceding a diagnosis of T2D,
60.0% of people showed IFG or Impaired Glucose Toler-
ance (IGT) [9]. Screening for diabetes is not different
from screening for IFG and the same risk factors associ-
ated with diabetes are associated with IFG [10]. Thus
targeting individuals with IFG/T2D for prevention and
control is of major importance to delay and/or prevent
the onset of diabetes and complications which are a
major cause of morbidity and mortality and highly re-
lated to duration, chronic levels of glycaemia and other
risk factors.
The current study was undertaken to investigate the
prevalence of modifiable risk factors and their associ-
ation with IFG/T2D to guide primary prevention and




A population-based survey to evaluate the burden of dia-
betes was conducted in Biyem-Assi, Yaoundé, Cameroon,
in 2007 as part of the Cameroon Burden of Diabetes
Project (CAMBoD), a multidisciplinary programme con-
tributing to surveillance, prevention and control of dia-
betes in urban areas [11]. Biyem Assi health district had
9.7% of health facilities of the centre region, Republic of
Cameroon, which comprised 25.1% of health facilities of
the country in 2011 [12]. Biyem Assi, an urban area, with
most inhabitants being government or private sector
workers earning a salary, business men and women or stu-
dents, has previously been shown to represent the urban
population in Yaoundé [13]. Based on a census enlisting
all adults aged 25 years and above living in the CAMoD
study area in Biyem-Assi, Yaoundé participants were in-
vited to participate in the 2007 survey. Multilevel system-
atic cluster sampling stratified by age group was used, a
cluster being a household. The first household was se-
lected randomly. Individual age group sampling was done
by which every age group was represented thus avoiding
having the sample size of the most populated age group
within a limited spatial surface. Survey participation rate
was 82.5% (n = 2062). Participants without the main
dependent variable (FCG) were excluded from the ana-
lyses resulting in an analytic study sample of 1623 study
participants.
Data collection and management
Teams of four trained interviewers, each including a
medical doctor, collected information on participants’
self-reported behavioural and lifestyle factors for chronic
diseases, blood pressure, anthropometry measurements
and blood samples for biochemical analysis from
September to October 2007 using standardized proce-
dures. For quality control purposes calibrated instruments
were used and adherence of trained interviewers to stan-
dardised procedures was monitored.
Participants were asked to fast overnight. For measure-
ment of fasting capillary glucose (FCG), study partici-
pants, who had not eaten or drank anything (except
plain water) for at least eight hours were visited at home
between 5:30 am and 9:00 am the next day. Assessment
of IFG/T2D was based on fasting capillary glucose mea-
surements with HemoCue®B-Glucose photometer, a vali-
dated instrument shown to give consistent readings as
compared to other instruments [14]. The participant’s
middle or ring finger, not bearing a ring, was cleaned
with an alcohol swab and pricked at the side with a lan-
cet. Blood was collected with a microcuvette, placed into
a cuvette holder and results displayed immediately [15].
HemoCue®B-Glucose photometers were controlled every
morning. Every sixth consecutive participant screened
negative was administered an oral glucose tolerance test
to ascertain reliability of results for FCG. IFG/T2D was
defined as fasting capillary glucose (FCG) ≥6.1 mmol/l
and/or on diabetes medication (insulin and/or anti-
diabetic drugs) [8], participants with FCG between
6.1 mmol/l and 6.9 mmol/l were considered to have
IFG, and those with FCG ≥7.0 mmol/l (126 mg/dl) and/
or on diabetes medication (insulin and/or anti-diabetic
drugs) were considered to have diabetes.
The World Health Organisation (WHO) STEPwise ap-
proach, a standardized questionnaire for chronic disease
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risk factor surveillance [16] including questions on dia-
betes and hypertension status (if diabetic or hypertensive
and whether on diabetes or hypertensive medication
(insulin and/or oral remedy)), smoking habits, alcohol
intake, dietary intake and physical activity was applied
by interviewers trained in the standardized administra-
tion of questionnaires in both English and French, the
official languages in Cameroon. Participants previously
on anti-diabetes medication and with FCG < 6.1 mmol/l
and, participants informed by a health professional that
s/he was diabetic but on local anti-diabetic remedy were
excluded. The instruments for the survey were pretested
and revised if indicated prior to the commencement of
the survey.
Systolic (SBP) and diastolic (DBP) blood pressure was
measured using fully automated calibrated Omron M3
machines with the participant being seated for at least
five minutes, legs uncrossed and the left arm resting on
a table prior to taking measurements. Blood pressure
was measured thrice, the mean of the second and third
measurement was considered for this study. Participants
with mean SBP ≥ 140 and/or DBP ≥ 90 mmHg and/or on
hypertensive medication were considered to be hyper-
tensive [17].
Anthropometric measurements, including weight (to
the nearest 0.1 kg, SECA scales), height (to the nearest
0.1 cm, locally made wood stadiometers), waist and hip
circumferences (to the nearest 0.1 cm, flexible inelastic
fibreglass meter band), were performed using standard
methods. Waist circumference was measured over light
clothing at the level of the midpoint between the inferior
margin of the last rib and the crest of the ilium in the
mid-axillary plane. Hip circumference was measured at
the level of the greater trochanter of the femur, -around
the buttocks through the symphysis pubis.
Obesity and central obesity were assessed by body
mass index (BMI), waist-to-hip ratio (WHR) and waist
circumference (WC). BMI was calculated as weight (kg)
divided by squared height (m2) and used to define nor-
mal weight (18.5 kg/m2 ≤ BMI < 25 kg/m2), overweight
(25 kg/m2 ≤ BMI < 30 kg/m2) and obesity (BMI ≥ 30 kg/m2)
[18,19]. WHR was calculated as waist (cm) divided by hip
(cm) circumference. Presence of abdominal obesity was
considered in case of elevated WHR (>1.0 for men
and >0.85 for women, respectively) or elevated waist
circumference (WC) (>102 cm for men and 88 cm for
women, respectively) [20-22].
Using the WHO STEPwise approach vigorous physical
activity was defined as sustained activity that results in a
significant increase in heart and breathing rate for at
least ten minutes at a time such as forestry, digging con-
struction, farm work or sporting activity. Moderate in-
tensity physical activity was defined as activity that
results in breathing somewhat harder than normal for at
least ten minutes such as cleaning, washing, planting
and harvesting crops, weaving, woodwork, brisk or quick
walking or carrying of light loads. Low intensity physical
activity was defined as involving mostly sitting or stand-
ing with walking for not more than ten minutes [23].
In addition, information on socioeconomic and demo-
graphic data, data on past and current medical history of
diabetes and its risk factors (tobacco smoking, alcohol
consumption, dietary habits, and physical activity) was
obtained from all study participants.
Data analysis
Means and standard deviations (SD) were used to de-
scribe continuous variables. Logistic regression was used
to investigate the association of demographic and an-
thropometric characteristics, blood pressure and lifestyle
risk factors to IFG/T2D. Sex, marital status and variables
significantly associated (two sided p-value < 0.05) with
IFG/T2D in univariate analyses were subsequently
included in multivariate logistic regression analyses. Re-
sults were reported as Odds Ratios (OR) with corre-
sponding 95% confidence intervals (95% CI). Statistical
correlations for the presence of IFG/T2D were assessed
between WHR and BMI, BMI and waist circumference,
and between sex and markers of central obesity and
BMI. Separate models were considered in case of correl-
ation between variables. We carried out direct age stand-
ardisation using World Health Organisation New World
Population as reference [24]. Regression analysis took
into consideration stratification, proportional weights
and clustering for participants with main dependent
variable having complete data. All statistical analyses
were adjusted for the cluster random sampling design by
use of the statistical software package STATA/IC (ver-
sion 11.1).
Ethical considerations
Prior to study inclusion participants gave informed con-
sent by either signing or thumb printing on the in-
formed consent form, a copy of which was given to the
participant. Information obtained from individuals and
households and results of the physical and biochemical
examinations were kept confidential. All participants
received individual feedback on the results of their
examinations and were referred where necessary to
Biyem-Assi hospital–Yaoundé for appropriate follow up.
Data were anonymized for statistical analysis. Ethical
clearance for the CAMBoD study was obtained from
the Cameroon National Ethics Committee; Yaoundé,
Cameroon; ethical clearance for analysis of the 2007 sur-
vey was given by the Human Research Ethics Committee
(Medical) of the University of the Witwatersrand,
Johannesburg, South Africa.
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Results
Demographic and socio-economic characteristics of study
participants
The study sample comprised 1623 participants, 666 men
(41.1%) and 957 women (58.9%). Average age was 39.7 (SD
12.9) years at the time of the survey in 2007. Demographic
characteristics, i.e. marital status, educational attainment
and information on occupation are given in Table 1.
Prevalence of IFG/Type 2 diabetes, hypertension and obesity
Prevalence of T2D was 3.3% (n = 54), 4.2% (n = 28)
among men and 2.7% (n = 26) among women. Figures
for IFG/T2D were 5.7% (n = 93), respectively 6.8% (n =
45) in men and 5.0% (n = 48) in women. Mean FCG was
5.4 mmol/l. IFG/T2D prevalence increased with age
(Table 2). Thirty-one (57.4%) of the 54 respondents con-
sidered to have T2D reported diabetes treatment; 42.6%
were newly diagnosed cases. Diabetes control was poor:
42.0% of diabetics on treatment had FCG ≥ 6.1 mmol/l,
29.0% had FCG ≥ 7.0 mmol/l.
Prevalence of hypertension was 26.6% and significantly
higher in older age groups (Table 2). Of the 432 partici-
pants considered to be hypertensive, 93 (21.5%) partici-
pants reported receiving treatment and 45 (10.4%) had
controlled blood pressure. The majority of study partici-
pants were overweight (34.5%) or obese (28.4%). Average
BMI of the study population was 27.6 kg/m2 (SD 5.4))
and was lower in men (25.9 (SD4.1) kg/m2 than women
(28.7 (SD 5.8) kg/m2). Women were more often obese
(37.0%) than men (16.1%); obesity was most prevalent in
the age group 45–54 years. More than a third of the
study participants (36.6%) showed elevated WHR,
slightly more pronounced in men (37.8%) than women
(35.7%). Elevated waist circumference was present in
34.9% of the study participants and was four times as
high in women (50.6%) as in men (12.5%). For both
parameters of central obesity a significant relation
with age was observed.
Prevalence of lifestyle factors – tobacco consumption,
alcohol consumption, physical activity and dietary habits
Most survey respondents were non-smokers (75.3%),
7.7% reported to be current smokers, the majority of
them being men (89.1%). Prevalence of current smoking
was most pronounced in the age group 35–44 years,
older age groups tended to report less current smoking.
On average current smokers started smoking at 21.2 (SD
5.9) years. Less than a third (28.%) of those who reported
to have smoked previously indicated to have stopped
because of health related problems; on average they re-
ported to have quit smoking at age 34.7 (SD 11.1) years.
Alcohol consumption was common with 65.5% of par-
ticipants reporting current alcoholic beverage consump-
tion such as beer, wine, spirit or local brews as palm
wine, corn beer, “bilibili”, “arki” or “afofo” and was most
prominent in those aged 25–34 years (men 91.2%,
women 78.5%). Men more often reported current alco-
hol consumption than women and were less often ab-
stainers. Beer was the most consumed alcoholic drink,
specifically in men (70.9%, women 49.8%) followed by
consumption of wine, palm wine, whisky, “bilibili” or
corn beer and “arki”.
Most respondents (61.5%) reported physical activity,
mostly low intensity physical activity (51.8%). Vigorous
physical activity was only reported by 4.3% of the partici-
pants. In general, intense physical activities were re-
ported more often by younger age groups and more
often by men than women (data not shown). For leisure/
recreational activities most study participants (85.9%) re-
ported light activities, vigorous intensity was only re-
ported by 6.1% of the study participants.
On average fruit consumption was reported on 3 days/
week, vegetable consumption on 2.4 days/week; less than
2.5% of respondents reported any vegetable consump-
tion, whereas 13.4% did not report any fruit consump-
tion. Older women reported highest fruit consumption.
Risk factors for IFG/T2D
Diabetic participants were often older, obese, hyperten-
sive, had elevated waist circumference and WHR, and
were less often single and more often retired (Table 1).
Age was significantly associated with IFG/T2D (Table 3).
Being obese was associated with increased likelihood of
IFG/T2D when compared to normal weight participants
(OR: 2.24, 95% CI: 1.33–3.78). Both markers of abdom-
inal obesity were associated with IFG/T2D, OR for ele-
vated WHR was 2.91 (95% CI: 1.99–4.25), OR for high
waist circumference was 2.23 (95% CI: 1.45–3.46).
Hypertension (OR = 2.11, 95% CI: 1.42–3.13) was also
associated with IGF/T2D (Table 3).
Gender and all variables significantly associated with
IFG/T2D in univariate models were included in multi-
variate logistic regression models to further analyse the
association with IFG/T2D. The two markers of abdom-
inal obesity were considered in separate multivariate logis-
tic regression analysis due to their high correlation. Both
markers were highly associated with IFG/T2D in multi-
variate adjusted models. Hosmer–Lemeshow goodness-
of-fit test confirmed the appropriateness of the two
multivariate adjusted models.
The factors that maintained their statistical signifi-
cance after multivariate adjustment were age (35–44
years: OR = 2.63, 95% CI: 1.26–5.51, p = 0.010; 45–54
years: OR = 3.05, 95% CI: 1.50–6.22, p < 0.002 and 55–64
years: OR = 5.88, 95% CI: 2.59–13.37, p < 0.001) and ele-
vated WHR (OR = 2.21, 95% CI: 1.22–4.01, p = 0.009)
(Table 3).
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Table 1 Description of study participants according to IFG/T2D status, Yaoundé, Cameroon, 2007
Variable All IFG/T2D Non IFG/T2D P-value*
(n = 1623) (n = 93) (n = 1530)
N % n % N %
Gender
Male 666 41.0 55 45.1 611 40.7
Female 957 59.0 67 54.9 890 59.3 0.345
Age group (years)
25-24 768 47.3 22 18.0 746 49.7
35-44 278 17.1 22 18.0 256 17.1
45-54 337 20.8 38 31.2 299 19.9
55-64 170 10.5 34 27.9 136 9.1
65+ 70 4.3 6 4.9 64 4.3 <0.001
Marital status
Married 852 52.5 84 68.9 768 51.2
Single 584 36.0 20 16.4 564 37.6
Others 187 11.5 18 14.8 169 11.3 <0.001
Occupation (n = 1526)
Civil servant/Private sector 591 38.7 51 46.4 540 38.1
Self-employed/unpaid subsistence farming 259 16.9 18 16.4 241 17.0
Student 197 12.9 4 3.6 193 13.6
Retired/House keeper 288 18.9 30 27.3 258 18.2
Unemployed 191 12.5 7 6.3 184 12.9 <0.001
Highest level of education (n = 1607)
Never went to school to completed primary school 366 22.8 31 25.6 335 22.5
Completed secondary school 405 25.2 30 24.8 375 25.2
Completed high school 391 24.3 27 22.3 364 24.5
Completed university 445 27.7 33 27.3 412 27.7 0.873
Weight status
Underweight to normal 593 36.5 30 24.6 563 37.5
Overweight 562 34.6 42 34.4 520 34.6
Obese 468 28.8 50 41.0 418 27.9 0.003
Waist-to-hip ratio
<0.90(men) or <0.85(women) 1029 63.4 48 39.3 981 65.4
>0.90(men) or >0.85(women) 594 36.6 74 60.7 520 34.6 <0.001
Waist circumference
≤94(men)≤ 80 cm(women) 743 45.8 40 32.8 703 46.8
94 > & < 102(men)80 > &88 cm (women) 313 19.3 18 14.8 295 19.7
≥102 cm(men)≥ 88 cm(women) 567 34.9 64 52.4 503 33.5 <0.001
Hypertension
Yes 432 26.6 51 41.8 381 25.4
No 1191 73.4 71 48.2 1120 74.6 <0.001
Smoking (n = 1 607)
Never 1219 75.9 91 75.8 1128 75.9
Former 266 16.5 19 15.8 247 16.6
Current 122 7.6 10 8.3 112 7.5 0.935
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Discussion and conclusions
The current study assessed the prevalence of and the
risk factor profile for IFG/T2D in the general adult
population in Biyem-Assi, Yaoundé, Cameroon and ob-
served age and central obesity to be the most important
risk factors associated with prevalence of IFG/T2D.
An increase in the prevalence of diabetes in this urban
area was observed from 2.0% in 1999 [4] to 3.3% in
2007. Regional and comparative prevalence in Africa
was 4.9% and 5.7% respectively and ranged from 4.4% to
7.0% in 2013 depending on the country’s economic de-
velopment [25]. A higher urban prevalence for diabetes
was observed in Tanzania for Asian Indians in 1991
(9.1%) and South Africa for Native Africans in 1993
(8.0%) [4].
In Zambia, the combined prevalence of impaired glu-
cose levels or diabetes in 2011 was 4.0% (impaired glu-
cose levels or diabetes defined as fasting glucose ≥
5.51 mmol/l) [26], higher than for this study most likely
due to a lower cut off point for IFG levels. A similar
study in China using the same cut off points for IFG and
T2D as in our study showed a higher prevalence of diag-
nosed diabetes, undiagnosed diabetes and IFG in adults
respectively; 1.3%, 4.2% and 7.3% [27], possibly in part
due to increased levels of physical inactivity, high levels
of alcohol consumption and poor dietary habits. Benefi-
cial effects of lifestyle behaviour to prevent or delay the
onset of diabetes and other health related benefits have
been demonstrated [28-30]. Prevalence estimates ob-
served in the current study were lower than estimates
for diabetes mellitus (5.7%) and IFG (4.5%) reported by a
systematic review and meta-analysis in sub-Saharan
Africa published in 2013 [31]. Disparities in prevalence
are probably in part due to differences in health determi-
nants across sub-Saharan Africa [31]. IFG is a risk state
prior to diabetes and ideally diabetes prevention strat-
egies identify and focus on individuals at pre-diabetes
state. Newly diagnosed cases represented 42.6% in our
study in contrast to more than 70% of newly diagnosed
cases reported for surveys [4]. This difference can be
Table 1 Description of study participants according to IFG/T2D status, Yaoundé, Cameroon, 2007 (Continued)
Alcohol consumption
Never 269 16.7 19 15.6 250 16.7
Former 293 18.2 23 18.9 270 18.1
Current 1051 65.1 80 65.5 971 65.1 0.935
General physical activity
None 628 38.6 37 30.3 591 39.4
Low intensity 837 51.6 73 59.8 764 50.9
Moderate activity 87 5.4 4 3.3 83 5.5
Vigorous activity 71 4.4 8 6.6 63 4.2 0.084
Walking/cycling for at least 10 minutes (n = 1 609)
Yes 1339 83.2 96 80.7 1 243 83.4
No 270 16.8 23 19.3 247 16.6 0.440
Activity during recreation/leisure (n = 1614)
None 89 5.5 2 1.7 87 5.8
Low intensity 1394 86.4 105 88.2 1 289 86.2
Moderate activity 42 2.6 4 3.4 38 2.5
Vigorous activity 89 5.5 8 6.7 81 5.4 0.251
Fruit consumption/week (n = 1 471)
0/day 299 20.3 26 22.0 273 20.2
1-2 days 252 17.1 29 24.6 223 16.5
3-4 days 731 49.7 44 37.3 687 50.8
5-7 days 189 12.9 19 16.1 170 12.5 0.025
Vegetable consumption/week(n = 1 555)
1-2 days 183 11.8 19 16.1 164 11.4
3-4 days 407 26.1 37 31.4 370 25.8
5-7 days 965 62.1 62 52.5 903 62.8 0.074
*Chi-square test for comparison of distribution of variable categories for IFG/T2D versus non IFG/T2D.
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Table 2 Percentage description of type 2 diabetes (T2D), Impaired fasting glucose (IFG)/T2D, hypertension, waist-hip-ratio, waist circumference and body mass
index by age group and by gender among 1623 study participants in Yaoundé, Cameroon, 2007
Men (n = 666) Women (n = 957)
25-34 35-44 45-54 55-64 >65 p-value7 25-34 35-44 45-54 55-64 >65 p-value7
N 666 317 100 116 100 33 957 451 178 221 70 37
Variable N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
T2D1 28 (4.2) 3 (10.7) 1 (3.6) 8 (28.6) 14 (50.0) 2 (7.1) <0.001 26 (2.7) 4 (15.4) 4 (15.4) 10 (38.5) 6 (23.1) 2 (7.7) <0.001
IFG/T2D2 45 (6.8) 5 (11.1) 8 (17.8) 9 (20.0) 21 (46.7) 2 (4.4) <0.001 48 (5.0) 9 (18.8) 8 (16.7) 20 (41.7) 8 (16.6) 3 (6.2) <0.001
Hypertension3 203 (30.5) 37 (18.2) 21 (10.3) 58 (28.6) 59 (29.1) 28 (13.8) <0.001 229 (23.9) 35 (15.3) 24 (10.5) 101 (44.1) 43 (18.8) 26 (11.4) <0.001
Weight status4
Normal weight 314 (47.2) 195 (62.1) 38 (12.1) 33 (10.5) 32 (10.2) 16 (5.1) 279 (29.2) 185 (66.3) 38 (13.6) 28 (10.0) 15 (5.4) 13 (4.7)
Overweight 243 (36.5) 95 (39.1) 41 (16.9) 54 (22.2) 44 (18.1) 9 (3.7) 319 (33.3) 157 (49.2) 60 (18.8) 71 (22.3) 22 (6.9) 9 (2.8)
Obese 109 (16.4) 27 (24.8) 21 (19.3) 29 (26.6) 24 (22.0) 8 (7.3) <0.001 359 (37.5) 109 (30.4) 80 (22.3) 122 (33.9) 33 (9.2) 15 (4.2) <0.001
Waist-hip-ratio5
Normal 414 (62.2) 280 (67.6) 58 (14.0) 40 (9.7) 29 (7.0) 7 (1.7) 615 (64.3) 340 (55.3) 118 (19.2) 116 (18.9) 29 (4.7) 12 (1.9)
Elevated 252 (37.8) 37 (14.7) 42 (16.7) 76 (30.2) 71 (28.2) 26 (10.3) <0.001 342 (35.7) 111 (32.5) 60 (17.5) 105 (30.7) 41 (12.0) 25 (7.3) <0.001
Waist circumference6
Normal 485 (72.8) 287 (59.2) 64 (13.2) 65 (13.4) 52 (10.7) 17 (3.5) 258 (27.0) 185 (71.7) 40 (15.5) 21 (8.1) 8 (3.1) 4 (1.6)
Increased risk 98 (14.7) 23 (23.5) 17 (17.4) 23 (23.5) 28 (28.6) 7 (7.1) 215 (22.5) 113 (52.6) 33 (15.4) 43 (20.0) 15 (7.0) 11 (5.1)
Elevated 83 (12.5) 7 (8.4) 19 (22.9) 28 (33.7) 20 (24.1) 9 (10.8) <0.001 484 (50.6) 153 (31.6) 105 (21.7) 157 (32.4) 47 (9.7) 22 (4.6) <0.001
1FCG > =7.0 mmol/l and /or on diabetes medication.
2FCG > =6.1 mmol/l and /or on diabetes medication.
3SBP ≥ 140 and /or DBP ≥ 90 mmHg and / or on hypertensive medication.
4Normal weight (18.5Kg/m2 ≤ BMI < 25Kg/m2), overweight (25Kg/m2 ≤ BMI < 30Kg/m2) and obese (BMI ≥ 30Kg/m2).
5Normal waist-hip-ratio < 1.0 for men and <0.85 for women and elevated waist-hip-ratio >1.0 for men and >0.85 for women.












Table 3 Risk factors for IFG/T2D in study participants aged 25 years and older in Yaoundé, Cameroon, 2007
Factors Univariate logistic regression Multivariate logistic regression
OR 95% CI P p for trend OR 95% CI p p for trend
Gender
Female 1 1
Male 1.19 0.82-1.74 0.352 0.352 1.23 0.73-2.07 0.443 0.332
Age Group
25-34 1 1
35-44 2.91 1.59-5.31 0.000 2.65 1.27-5.53 0.009
45-54 4.31 2.53-7.32 0.000 3.04 1.50-6.14 0.002
55-64 8.48 4.67-15.37 0.000 5.69 2.52-12.83 0.000
65+ 3.18 1.28-7.90 0.013 <0.001 1.88 0.60-5.86 0.275 <0.001
Marital status
Married 1
Single 0.32 0.19-0.54 0.000
Others 0.97 0.50-1.88 0.937 0.119
Weight status
Normal 1 1
Overweight 1.52 0.90-2.55 0.117 0.92 0.47-1.80 0.810
Obese 2.24 1.33-3.78 0.002 0.002 1.14 0.56-2.34 0.704 0.503
Waist-hip ratio
<1.0 (men) or <0.85 (women) 1 1
>1.0 (men) or >0.85 (women) 2.91 1.99-4.25 0.000 <0.001 2.21 1.22-4.01 0.009 0.008
Waist circumference in cm
≤94 (men) or ≤80 (women) 1 1
94 > & < 102 (men) or 80 > & < 88 (women) 1.07 0.59-1.96 0.821 0.71 0.33-1.53
≥102 (men) or ≥88 (women) 2.23 1.45-3.46 0.000 <0.001 1.08 0.48-2.47 0.850 0.798
Prevalence of hypertension
No 1 1
Yes 2.11 1.42-3.13 0.000 <0.001 1.58 0.92-2.72 0.100 0.145
Smoking
Never 1
Former 0.95 0.57-1.60 0.857
Current 1.11 0.56-2.19 0.771 0.888
Alcohol consumption
Never drank 1
Former 1.12 0.57-2.21 0.743
Current 1.08 0.65-1.81 0.758 0.820
General physical activity
None 1
Low intensity 1.53 0.96-2.42 0.073
Moderate activity 0.77 0.26-2.29 0.637
Vigorous activity 2.03 0.88-4.69 0.098 0.111
Kufe et al. BMC Public Health Page 8 of 10
most likely attributed to on-going sensitisation cam-
paigns in the study area to curb diabetes [12]. The ob-
served associations of age and central obesity with IFG/
T2D in this Cameroonian population are in accordance
with previous international observations [4-6], in par-
ticular central obesity was observed to be a good pre-
dictor of IFG/T2D. Waist circumference has previously
been shown in a Cameroonian population to be posi-
tively associated to all obesity related abnormalities [32].
We observed no association between fruit and vege-
table consumption and IFG/T2D, despite previous re-
ports on an inverse association of these low energy
density, low glycaemic load, and high fibre and micronu-
trient content foods with risk of developing IFG/T2D
[33,34]. Our results may in part be explained by poor
quantification of the type and amounts of fruits and veg-
etables consumed with the interviewer-administered
questionnaire and with seasonal availability of these pro-
duce on the local market.
Likewise, we observed no associations for current and
former smokers with IFG/T2D, nor an inverse associ-
ation for moderate alcohol intake or physical activity
with IFG/T2D [35-38] pointing towards methodological
challenges of the WHO-STEPS tool applied for assess-
ment of risk factors in this population in Cameroon.
These may entail for example for physical activity, diffi-
culties in interpretation of the physical activity ques-
tions, e.g. perception of categories of physical activity on
the one side and on the other side the notion that some
leisure/recreational physical activities in Cameroon are
rather considered to be social occasions coupled with
entertainment including alcohol and food consumption
potentially offsetting the beneficial effects that accrue
from physical activity.
The results reported in the current study are based on
the CAMBoD survey conducted in the adult population
of Biyem-Assi, Yaoundé, Cameroon in 2007. In compari-
son with a survey conducted in the area in 2003
increased prevalence for IFG/T2D ((3.7% (2003) to 4.1%
(2007), hypertension (17.1% (2003) to 20.4% (2007))
and obesity (14.6% (2003) to 18.3% (2007); all age-
standardized data) were noted. Our study showed that
T2D, IFG/T2D, hypertension and adiposity affects par-
ticularly people in the age group 45-54 years. Prevalence
has increased though less than for any of the top 10
countries in the African region for which increasing
prevalence of 6.3% to 15.4% was reported in 2013 [25].
Urban settlements are fast becoming diabetic and obes-
ity epi-centres and increasingly people at younger ages
are observed to develop diabetes [2,4,5]. The high bur-
den of diabetes in low and middle income countries es-
pecially in sub-Saharan Africa [25,31] calls for increased
efforts to address individual lifestyle changes to reduce
modifiable IFG/T2D risk factors [28,29], particularly
central obesity, to counteract accelerating prevalence
rates of IFG/T2D in a population undergoing rapid
urbanisation and epidemiologic transition with limited
health resources accentuated by negligible health ex-
penditure on diabetes.
Limitations and advantages of the study
The current cross-sectional study was conducted in an
urban setting in Yaoundé and may thus not be
generalizable to the rural population in Cameroon.
Missing information in the survey population may fur-
ther limit the generalizability of the study results. For
definition of pre-diabetes, we used IFG instead of IGT,
which considering that FCG may potentially fail to
identify previously undiagnosed diabetes, could have
introduced misclassification of IFG/T2D. Participants
on anti-diabetic medication were considered to be
diabetic, however, some may have been prescribed
anti-diabetic medication at a pre-diabetes stage, which
might have resulted in some misclassification of IFG
and T2D.
Despite these limitations and taking into consideration
feasibility, reproducibility, acceptability and local context
our study provided prevalence data of T2D, IFG/T2D,
hypertension and adiposity by sex and age group strata
for an urban Cameroonian population. The study seeks
to enhance public awareness on the seriousness of dia-
betes and its complications and the need for prevention
strategies especially in people less than 45 years of age.
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